Pramipexole Dihydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers, 24 USDMF, 18 CEP/COS, 2 JDMF, 17 EU WC, 10 KDMF, 12 NDC API, 29 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

8 Suppliers

8 Suppliers

DOSSIERs // Finished Dosage Forms

695 Dossiers, 181 FDA Orange Book, 345 Europe, 34 Canada, 37 Australia, 29 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 23 Roquette, 18 Kerry, 16 SPI Pharma, 16 Corel Pharma Chem, 11 Microlex e.U, 10 BASF, 9 Sigachi Industries, 9 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 5 Boai NKY Pharmaceuticals Ltd, 5 Lubrizol Life Science Health, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Ulanqab Kema New Material, 2 Pharmatrans-Sanaq, 2 DKSH, 2 DFE Pharma, 2 The Dow Chemical Company, 2 Prachin Chemical, 2 Vasa Pharmachem, 2 Rochem International Inc, 1 Pfanstiehl, 1 Pharm-RX Chemical, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 32 Thickeners and Stabilizers, 31 Direct Compression, 30 Controlled & Modified Release, 22 Taste Masking, 21 Solubilizers, 18 Granulation, 15 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Disintegrants & Superdisintegrants, 9 Film Formers & Plasticizers, 7 Topical, 7 API Stability Enhancers, 6 Parenteral, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 237 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS

14 US Patents, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 BioAnalytical Methods, 3 EDQM Standards, 3 USP Standards, 16 Other Ref. Standards

DIGITAL CONTENT

19 News

19 News

Pharmacy pricing data of Pramipexole Dihydrochloride obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Pramipexole Dihydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers

24 USDMF

18 CEP/COS

2 JDMF

17 EU WC

10 KDMF

12 NDC API

29 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Forms

695 Dossiers

181 FDA Orange Book

345 Europe

34 Canada

37 Australia

29 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

23 Roquette

18 Kerry

16 SPI Pharma

16 Corel Pharma Chem

11 Microlex e.U

10 BASF

9 Sigachi Industries

9 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Gangwal Chemicals

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

5 Boai NKY Pharmaceuticals Ltd

5 Lubrizol Life Science Health

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

3 Kima Chemical

3 Ulanqab Kema New Material

2 Pharmatrans-Sanaq

2 DKSH

2 DFE Pharma

2 The Dow Chemical Company

2 Prachin Chemical

2 Vasa Pharmachem

2 Rochem International Inc

1 Pfanstiehl

1 Pharm-RX Chemical

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 Shijiazhuang Huaxu Pharmaceutical

1 Qualicaps

1 Shanghai Welltone Material Technology Co., Ltd

1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders

43 Coating Systems & Additives

32 Thickeners and Stabilizers

31 Direct Compression

TABLET;ORAL - 0.125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons